Leaders in pulmonary hypertension

Neil Davie, Ph.D.

Head, Late Development
Cardiovascular, Metabolism & Pulmonary Hypertension

Neil Davie, Ph.D. is the Head, Late Development, of Cardiovascular, Metabolism, & Pulmonary Hypertension (CVM & PH). He has extensive experience as a drug developer leading projects across multiple therapeutic areas, particularly in specialty/rare diseases with high unmet medical need.
Emmanuelle Quilès

Worldwide Vice President
Cardiovascular, Metabolism and Pulmonary Hypertension
Janssen Global Commercial Strategy Organization (GCSO)

Emmanuelle Quilès is Worldwide Vice President, Cardiovascular, Metabolism and Pulmonary Hypertension. In this role, working closely with R&D, Emmanuelle is focusing on maximizing the value of Janssen’s Cardiovascular & Metabolism (CVM) and Pulmonary Hypertension (PH) pipelines and marketed assets.